[Topical glycopyrronium bromide as a cause of pupillary changes].Ugeskr Laeger 2026 Apr 20; 188(17).UL
Abstract
Topical glycopyrronium bromide is an acetylcholine receptor antagonist approved for the treatment of severe primary axillary hyperhidrosis in adults. The ointment is often prescribed off-label for hyperhidrosis on palms and soles. This case report presents ocular side effects after topical glycopyrronium bromide use, leading to several clinical follow-ups and diagnostic tests. This case report underscores the importance of recognising potential side effects for clinicians, especially in off-label treatment.
MeSH
Pub Type(s)
Journal Article
Case Reports
English Abstract
Language
dan
PubMed ID
42059515
Citation
Hjorth, Marie Kirstine, et al. "[Topical Glycopyrronium Bromide as a Cause of Pupillary Changes]." Ugeskrift for Laeger, vol. 188, no. 17, 2026.
Hjorth MK, Hansen AK, Brost AG, et al. [Topical glycopyrronium bromide as a cause of pupillary changes]. Ugeskr Laeger. 2026;188(17).
Hjorth, M. K., Hansen, A. K., Brost, A. G., & Lund, T. T. (2026). [Topical glycopyrronium bromide as a cause of pupillary changes]. Ugeskrift for Laeger, 188(17). https://doi.org/10.61409/V08250652
Hjorth MK, et al. [Topical Glycopyrronium Bromide as a Cause of Pupillary Changes]. Ugeskr Laeger. 2026 04 20;188(17) PubMed PMID: 42059515.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Topical glycopyrronium bromide as a cause of pupillary changes].
AU - Hjorth,Marie Kirstine,
AU - Hansen,Anne Kragh,
AU - Brost,Agnes Galbro,
AU - Lund,Tamara Theresia,
Y1 - 2026/04/20/
PY - 2026/4/30/medline
PY - 2026/4/30/pubmed
PY - 2026/4/30/entrez
JF - Ugeskrift for laeger
JO - Ugeskr Laeger
VL - 188
IS - 17
N2 - Topical glycopyrronium bromide is an acetylcholine receptor antagonist approved for the treatment of severe primary axillary hyperhidrosis in adults. The ointment is often prescribed off-label for hyperhidrosis on palms and soles. This case report presents ocular side effects after topical glycopyrronium bromide use, leading to several clinical follow-ups and diagnostic tests. This case report underscores the importance of recognising potential side effects for clinicians, especially in off-label treatment.
SN - 1603-6824
UR - https://www.unboundmedicine.com/prime/citation/42059515/[Topical_glycopyrronium_bromide_as_a_cause_of_pupillary_changes].
DB - PRIME
DP - Unbound Medicine
ER -
